학술논문

Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis
Document Type
Article
Source
In: Pediatric Blood and Cancer. (Pediatric Blood and Cancer, May 2014, 61(5):879-884)
Subject
Language
English
ISSN
15455017
15455009